The plasma fractionation market growth continues to demonstrate resilience as the immunoglobulin segment experiences sustained demand expansion driven by broadening indications beyond primary immunodeficiency into neurological, autoimmune, and infectious disease applications. Intravenous and subcutaneous immunoglobulin therapies are increasingly utilized for chronic inflammatory demyelinating...